Systematic Review of Visceral Leishmaniasis in Central Africa
Demba Kodindo Israël, Cheick Amadou Coulibaly, John C. Beier, Gunter C. Muller, Seydou Doumbia
Asian Journal of Medicine and Health · pp. 8–20 · Published 30 Jun 2021
10.9734/ajmah/2021/v19i730341Abstract
In underdeveloped countries, infectious diseases remain one of the most important public health challenges. Visceral leishmaniasis, also known as Kala-azar, is a lethal vector-borne parasitic disease with an increasing number of cases. However, it remains one of the most neglected diseases in the world. It is the most severe form of leishmaniasis and is endemic in 75 countries. Around 95% of the patients live in seven countries: Brazil, Ethiopia, India, Kenya, Somalia, South Sudan, and causes about 20,000-40,000 deaths per year of which 50-70% are children. In Central Africa, this pathology is little known and less documented, making it difficult to access information. We have performed this study to characterize the knowledge on the epidemiology of visceral leishmaniasis in Central Africa. We reviewed the literature on visceral leishmaniasis in Central Africa on the number of reported cases, identified parasites, reservoirs and vectors. The documents consulted came from WHO reports, publications of scientific journals, reports of research institutions and abstracts of scientific conferences consulted online on Pubmed and Google Scholar. The information covers the period from the first reporting of cases in each country until December 2020. The review of the situation of visceral leishmaniasis revealed that it is not a significant public health problem in Central Africa. However, a lot of work remains to be done especially surveillance and research in order to present the exact situation of the disease in this part of the continent. This work would include the underreporting of cases inherent to the weaknesses of the surveillance system in these countries, the clarification of the transmission dynamics of human visceral leishmaniasis, canine leishmaniasis, the identity of parasites and vectors.
Cited by 3
Julia Andrés-Rodríguez, María-Cristina González-Montero, Nerea García-Fernández · International Journal for Parasitology: Drugs and Drug Resistance · 2025
Thierry Rostand Tebo-Nzesseu, Ngouateu Aime Tateng, Omer Bébé Ngouateu · Frontiers in Tropical Diseases · 2024
Omer Bébé Ngouateu, B. Dondji · Current Research in Parasitology and Vector-Borne Diseases · 2022
Related research
- The Nature and Complications of Acute Traumatic Cervical Spinal Cord Injury in a University Hospital in Nigeria — shares topic coverage
- Risk Factors Assessment of Zoonotic Anthrax among the People at Risk (PAR) in Selected Areas of Bangladesh — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Administration of High-Risk Medication: A Hospital Based Prospective Study — shares topic coverage
- Five Year Survival Rate of Adolescents and Young Adults (AYA) Cancer Patients: A Prospective Fixed Cohort Study in Bangladesh — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
3
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.